Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Reproduction. 2017 May 3;154(1):67–77. doi: 10.1530/REP-17-0039

Figure 2.

Figure 2

Placental RLNH2 and fetoplacental growth. Examples of placental RLNH2 immunostaining in (A) Uw/N, (B) Ow/Ob, and (C) negative control. RLNH2 immunostained the syncytiotrophoblast (ST) and villous vascular endothelial cells (EC). (D) Quantitation for all subjects (N=69) showed that placental weight increased as syncytiotrophoblast RLNH2 increased (P=0.038). (E) Syncytiotrophoblast RLNH2 also increased in Ow/Ob compared to Uw/N subjects (P=0.017). (F) Plotted for individual subjects, syncytiotrophoblast RLNH2 increased with placental weight for both Uw/N (closed circles) (N=25) and Ow/Ob (open squares) (N=44). (G) Placental weight was inversely related to placental RLNH2 mRNA for Uw/N (closed circles) (P=0.018), but not Ow/Ob (open squares) (P=0.098). Original magnification 400x.